In PMNs, the median levels of N-cadherin, CK18, and CK19 expression were 1.698, 0.706, and 0.350 in breast cancer patients and 0.851, 0.249, and 0.167 in HVs, respectively. This evidence concerns the gene KRT18 and breast carcinoma.